Atlas Capital Advisors’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-1,967
Closed -$195K 688
2019
Q3
$195K Buy
+1,967
New +$187K 0.06% 321

Other funds holding CELG

Atlas Capital Advisors's CELG Position: Q4 2019 in Review

Atlas Capital Advisors sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 1,967 shares — an estimated $195K sold.

Atlas Capital Advisors first reported a position in CELG in Q3 2019 and held it in 1 quarter. The position peaked at $195K in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Atlas Capital Advisors reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Atlas Capital Advisors sold 1,967 Celgene Corp shares in Q4 2019, an estimated $195K.
  • Atlas Capital Advisors first reported a position in Celgene Corp in Q3 2019 and held it in 1 quarter.
  • Atlas Capital Advisors's Celgene Corp position peaked at $195K in Q3 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Atlas Capital Advisors's 13F filing for Q4 2019, filed 28 Jan 2020.